Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Synthesis and Anticancer Activity of Novel 9-O-Substituted Berberine Derivatives.

Milata V, Svedova A, Barbierikova Z, Holubkova E, Cipakova I, Cholujova D, Jakubikova J, Panik M, Jantova S, Brezova V, Cipak L.

Int J Mol Sci. 2019 May 1;20(9). pii: E2169. doi: 10.3390/ijms20092169.

2.

Sodium/calcium exchanger is involved in apoptosis induced by H2S in tumor cells through decreased levels of intracellular pH.

Szadvari I, Hudecova S, Chovancova B, Matuskova M, Cholujova D, Lencesova L, Valerian D, Ondrias K, Babula P, Krizanova O.

Nitric Oxide. 2019 Jun 1;87:1-9. doi: 10.1016/j.niox.2019.02.011. Epub 2019 Mar 5.

PMID:
30849492
3.

Salidroside, a Chemopreventive Glycoside, Diminishes Cytotoxic Effect of Cisplatin in Vitro.

Zduriencikova M, Cholujova D, Duraj J, Mastihubova M, Mastihuba V, Karnisova Potocka E, Galova E, Sevcovicova A, Klapakova M, Horvathova E.

Basic Clin Pharmacol Toxicol. 2018 Mar;122(3):346-354. doi: 10.1111/bcpt.12906. Epub 2017 Oct 11.

4.

Plasma Cytokines Correlated With Disease Characteristics, Progression-Free Survival, and Overall Survival in Testicular Germ-Cell Tumor Patients.

Svetlovska D, Miskovska V, Cholujova D, Gronesova P, Cingelova S, Chovanec M, Sycova-Mila Z, Obertova J, Palacka P, Rajec J, Kalavska K, Usakova V, Luha J, Ondrus D, Spanik S, Mardiak J, Mego M.

Clin Genitourin Cancer. 2017 Jun;15(3):411-416.e2. doi: 10.1016/j.clgc.2017.01.027. Epub 2017 Feb 8.

PMID:
28237180
5.

Sulforaphane-induced apoptosis involves the type 1 IP3 receptor.

Hudecova S, Markova J, Simko V, Csaderova L, Stracina T, Sirova M, Fojtu M, Svastova E, Gronesova P, Pastorek M, Novakova M, Cholujova D, Kopacek J, Pastorekova S, Sedlak J, Krizanova O.

Oncotarget. 2016 Sep 20;7(38):61403-61418. doi: 10.18632/oncotarget.8968.

6.

Modulation of cisplatin sensitivity in human ovarian carcinoma A2780 and SKOV3 cell lines by sulforaphane.

Hunakova L, Gronesova P, Horvathova E, Chalupa I, Cholujova D, Duraj J, Sedlak J.

Toxicol Lett. 2014 Nov 4;230(3):479-86. doi: 10.1016/j.toxlet.2014.08.018. Epub 2014 Aug 23.

PMID:
25159039
7.

Increased production of IL-6 and IL-17 in lipopolysaccharide-stimulated peripheral mononuclears from patients with rheumatoid arthritis.

Chovanova L, Vlcek M, Krskova K, Penesova A, Radikova Z, Rovensky J, Cholujova D, Sedlak J, Imrich R.

Gen Physiol Biophys. 2013 Sep;32(3):395-404. doi: 10.4149/gpb_2013043. Epub 2013 Jul 2.

PMID:
23817641
8.

Detection of glycomic alterations induced by overexpression of p-glycoprotein on the surfaces of L1210 cells using sialic acid binding lectins.

Bubencíkova T, Cholujová D, Messingerová L, Mislovicova D, Seres M, Breier A, Sulova Z.

Int J Mol Sci. 2012 Nov 16;13(11):15177-92. doi: 10.3390/ijms131115177.

9.

MGN-3 arabinoxylan rice bran modulates innate immunity in multiple myeloma patients.

Cholujova D, Jakubikova J, Czako B, Martisova M, Hunakova L, Duraj J, Mistrik M, Sedlak J.

Cancer Immunol Immunother. 2013 Mar;62(3):437-45. doi: 10.1007/s00262-012-1344-z. Epub 2012 Sep 2.

PMID:
22941038
10.

Tunicamycin depresses P-glycoprotein glycosylation without an effect on its membrane localization and drug efflux activity in L1210 cells.

Sereš M, Cholujová D, Bubenčíkova T, Breier A, Sulová Z.

Int J Mol Sci. 2011;12(11):7772-84. doi: 10.3390/ijms12117772. Epub 2011 Nov 10.

11.

Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma.

Jakubikova J, Cervi D, Ooi M, Kim K, Nahar S, Klippel S, Cholujova D, Leiba M, Daley JF, Delmore J, Negri J, Blotta S, McMillin DW, Hideshima T, Richardson PG, Sedlak J, Anderson KC, Mitsiades CS.

Haematologica. 2011 Aug;96(8):1170-9. doi: 10.3324/haematol.2010.029363. Epub 2011 Jun 28.

12.

Chemically mimicked hypoxia modulates gene expression and protein levels of the sodium calcium exchanger in HEK 293 cell line via HIF-1α.

Hudecova S, Lencesova L, Csaderova L, Sirova M, Cholujova D, Cagala M, Kopacek J, Dobrota D, Pastorekova S, Krizanova O.

Gen Physiol Biophys. 2011 Jun;30(2):196-206. doi: 10.4149/gpb_2011_02_196.

PMID:
21613675
13.

Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications.

Jakubikova J, Adamia S, Kost-Alimova M, Klippel S, Cervi D, Daley JF, Cholujova D, Kong SY, Leiba M, Blotta S, Ooi M, Delmore J, Laubach J, Richardson PG, Sedlak J, Anderson KC, Mitsiades CS.

Blood. 2011 Apr 28;117(17):4409-19. doi: 10.1182/blood-2010-02-267344. Epub 2011 Feb 14.

14.

Comparative study of four fluorescent probes for evaluation of natural killer cell cytotoxicity assays.

Cholujová D, Jakubíková J, Kubes M, Arendacká B, Sapák M, Ihnatko R, Sedlák J.

Immunobiology. 2008;213(8):629-40. doi: 10.1016/j.imbio.2008.02.006. Epub 2008 Apr 28.

PMID:
18765168
15.

Effective gene transfer to melanoma cells using bacterial ghosts.

Kudela P, Paukner S, Mayr UB, Cholujova D, Kohl G, Schwarczova Z, Bizik J, Sedlak J, Lubitz W.

Cancer Lett. 2008 Apr 8;262(1):54-63. doi: 10.1016/j.canlet.2007.11.031. Epub 2007 Dec 31.

PMID:
18164809
16.

Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasiveness.

Kankuri E, Cholujova D, Comajova M, Vaheri A, Bizik J.

Cancer Res. 2005 Nov 1;65(21):9914-22.

17.

Bacterial ghosts as novel efficient targeting vehicles for DNA delivery to the human monocyte-derived dendritic cells.

Kudela P, Paukner S, Mayr UB, Cholujova D, Schwarczova Z, Sedlak J, Bizik J, Lubitz W.

J Immunother. 2005 Mar-Apr;28(2):136-43.

PMID:
15725957

Supplemental Content

Loading ...
Support Center